Related by context. All words. (Click for frequent words.) 86 imatinib Gleevec ® 84 erlotinib Tarceva ® 84 dasatinib Sprycel ® 76 cetuximab Erbitux R 76 PEGylated Fab fragment 75 bevacizumab Avastin R 75 CYT# potent vascular disrupting 75 nilotinib Tasigna ® 75 Oral Fingolimod 75 Mg Usa 75 5 FU leucovorin 74 TNF Tumor Necrosis Factor 74 FUSILEV enhances 74 Pharmacokinetics PK 74 Study Evaluating 74 TO AVOID PREGNANCY WHILE 74 evaluating tivozanib 74 R Saizen R 74 Xeloda ® 74 Novel Oral 74 D aspartate NMDA receptor 74 CYP#A# CYP#D# 74 Ovitrelle R Serostim 74 oral prodrug 74 irinotecan doxorubicin oxaliplatin paclitaxel 74 selective antagonist 73 imatinib resistant 73 highly selective inhibitor 73 dasatinib Sprycel 73 novel VDA molecule 73 Anti Tumor 73 essential thrombocythemia ET 73 PKC# 73 IAP inhibitor 73 alfa 2a 73 brand ciclesonide HFA 73 sodium glucose cotransporter 73 thalidomide Thalomid 73 Hsp# Inhibitor 73 vapreotide acetate 73 refractory chronic lymphocytic 73 bevacizumab Avastin ® 73 erlotinib Tarceva R 73 metastatic malignant 72 AAG geldanamycin analog 72 itraconazole Sporanox 72 Meets Primary Endpoint 72 MAGE A3 ASCI 72 adalimumab Humira 72 NS5B polymerase 72 Zorbtive TM 72 Chronic Hepatitis C 72 pan HDAC inhibitor 72 receptor tyrosine kinase inhibitor 72 developing Bicifadine serotonin 72 Kinase Inhibitor 72 Phase 2b Clinical Trial 72 Factor Receptor 72 hypertrichosis occurred 72 non nucleoside inhibitor 72 orally administered inhibitor 72 advanced metastatic renal 72 R lenalidomide 72 liposomal formulation 72 Mg Uk 72 FEMALES SHOULD BE ADVISED 72 including cyclosporine methotrexate 72 cisplatin gemcitabine 72 interferon beta 1a infertility 72 RON Notch 72 Vitro Activity 72 Peginterferon Alfa 2a 72 ergot derivatives 72 ATRA IV 71 Copegus ® 71 proteasome inhibitor 71 Complicated Skin 71 Omacetaxine 71 formerly LymphoStat B 71 Blinatumomab 71 lenalidomide Revlimid R 71 virus HCV protease inhibitor 71 leukemia CLL 71 CD4 monoclonal antibody 71 refractory chronic myeloid 71 pralatrexate injection folate analogue 71 tumor xenograft models 71 chronic eosinophilic leukemia 71 accumulate preferentially 71 alpha folate receptor 71 Enzastaurin 71 Epratuzumab 71 Vidaza ® 71 ara C 71 selective modulator 71 Phase IIb Trial 71 PEGylated anti 71 EGFR HER2 71 familial amyloidotic polyneuropathy FAP 71 LymphoStat B belimumab 71 Aflibercept 71 Antitumor Activity 71 Camptosar ® 71 Xanafide 71 ADP receptor antagonist 71 BCG refractory carcinoma 71 2 methoxyestradiol 71 Refractory Hodgkin Lymphoma 71 Irinotecan 71 gefitinib Iressa 71 trastuzumab Herceptin R 71 imatinib Gleevec 71 Relapsed Refractory 71 intravesical infusion therapy 71 HuCAL PLATINUM ® CysDisplay 71 humanized anti 71 Obatoclax 71 ritonavir boosted 71 Dasatinib 71 tumors GIST 71 PRN FDA Approves 71 myelofibrosis polycythemia vera 71 Randomized Double blind 71 Tezampanel 71 oral chemotherapeutic agent 71 Ceftaroline 71 Voreloxin 71 Prolongs Survival 71 Bosutinib 71 EGFr expressing metastatic colorectal 71 pegylated liposomal doxorubicin 71 rHuPH# recombinant human 71 beta 1a 71 TRANSDUR ® 71 Phase 2b Trial 71 adriamycin 71 Doxil ® 71 Pegasys ® 71 FOLFOX6 chemotherapy regimen 70 COPEGUS R 70 plus prednisone prednisolone 70 Naive Patients 70 dependent kinase inhibitor 70 abacavir sulfate lamivudine 70 IMiDs ® 70 Tipranavir 70 irreversible inhibitor 70 R metformin Concor 70 Fludarabine 70 Phase 2a Clinical Trial 70 Fulvestrant 70 steroid refractory ulcerative 70 docetaxel Taxotere ® 70 pan histone deacetylase 70 XL# anticancer compounds 70 temsirolimus Torisel 70 5 Fluorouracil 70 Nilotinib 70 recurrent glioblastoma multiforme 70 dexamethasone Decadron 70 immunomodulating 70 ® lenalidomide 70 agonistic human 70 voriconazole 70 Talabostat 70 methicillin susceptible 70 SPRYCEL ® 70 Pruvel TM 70 MKC# MT 70 Panzem R 70 mapatumumab 70 Vidofludimus 70 mu opioid receptor antagonist 70 gemcitabine cisplatin 70 metastatic castration resistant 70 vinca alkaloid 70 HGS ETR1 mapatumumab 70 inflammatory PDE 70 myelodysplastic myeloproliferative diseases 70 GW# [003] 70 ERBITUX cetuximab 70 peripherally restricted 70 Albuferon TM 70 targeted antifolate 70 protein tyrosine phosphatase 1B 70 indinavir Crixivan 70 R bisoprolol Euthyrox 70 VEGFR2 inhibitor 70 cardiometabolic diseases Glucophage 70 novel topoisomerase 70 FOLFOX6 70 cetuximab Erbitux ® 70 Randomized Phase 70 reversible inhibitors 70 Serostim ® 70 polymerase inhibitor 70 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 70 Romiplostim 70 Pemetrexed 70 topical gel formulation 70 FDA APPROVES 70 q8h 70 Paraplatin ® 70 Omacetaxine mepesuccinate 70 Diffuse Large B 70 Polymerase Inhibitor 70 R roscovitine CDK cyclin 70 cyclophosphamide methotrexate 70 hypereosinophilic syndrome 70 sorafenib tablets 70 Elotuzumab 70 Trial Evaluating 70 Fludara ® 70 alpha 2a 70 Peginterferon 70 3TC lamivudine Epivir 70 includes S. anginosus 70 triggers apoptosis programmed 70 Carfilzomib 70 Antitumor 70 protein kinase inhibitor 70 kidney urologic 70 Combination REOLYSIN R 70 Alfacell proprietary ribonuclease 70 Eculizumab 70 evaluating picoplatin 70 By JENNIFER LEARN 69 investigational oral inhibitor 69 Previously Treated 69 BAL# [001] 69 multi kinase inhibitor 69 monoclonal antibody IgG1 Mab 69 Investigational Oral 69 Philadelphia Chromosome Positive 69 ZOLINZA 69 ENMD # 69 tigecycline 69 NR2B selective 69 pathophysiological effects 69 fosbretabulin 69 Aplidin R 69 Refractory Peripheral T 69 cell lymphoma CTCL 69 events thrombocytopenia neutropenia 69 See CLINICAL PHARMACOLOGY 69 somatropin Kuvan R 69 antibody MT# 69 Atripla combines 69 CD# monoclonal antibody 69 Amgen Neulasta R 69 cytidine nucleoside analog 69 II TRISENOX R 69 somatostatin analog 69 INVANZ 69 abacavir lamivudine 69 PROCTOCORT R 69 Gleevec resistant 69 demonstrated antitumor activity 69 Relapsing Multiple Sclerosis 69 ALN HPN 69 sapropterin dihydrochloride 69 ganetespib 69 Interferon alfa 2b 69 triciribine phosphate monohydrate 69 Cutaneous T 69 Gemzar ® 69 humanized interleukin 6 69 BY ROB WEILER 69 mertansine 69 investigational humanized monoclonal antibody 69 Glufosfamide 69 Panzem NCD 69 Sapacitabine 69 Crofelemer budesonide foam 69 peptidic compound 69 dextromethorphan quinidine 69 CYP#A# substrate 69 apoptosis proteins 69 refractory cutaneous T 69 Mylan Receives Approval 69 Nitazoxanide 69 EOquin TM phase 69 HGS ETR2 69 vinca alkaloids 69 Plaque Psoriasis 69 Anti Tumor Activity 69 Myelofibrosis 69 bortezomib Velcade R 69 Trastuzumab 69 ALVESCO ® 69 sorafenib Nexavar 69 Phospholipase A2 69 Severe Sepsis 69 CYP#A# isoenzyme 69 Traficet EN 69 biologic DMARD 69 anti leukemic 69 Perifosine KRX 69 Pooled Analysis 69 selective A2A adenosine receptor 69 IN PATIENTS WITH 69 alpha 2b 69 gemcitabine Gemzar 69 Lenalidomide 69 Selective Inhibitor 69 administered concomitantly 69 estramustine 69 Monotherapy 69 Belimumab 69 Well Tolerated 69 Ribavirin causes 69 oral dihydropyrimidine dehydrogenase DPD 69 CTAP# Capsules 69 % hydrocortisone acetate 69 Demonstrates Potent 69 Randomized Double Blind 69 Peginterferon alfa 2b 69 Copegus ribavirin 69 Epidermal Growth Factor Receptor 69 T#I mutant 69 First Patient Dosed 69 Completes Patient Enrollment 69 relapsed refractory multiple myeloma 69 Humanized Anti 69 Therapy RecoveryRx TM 69 selective kinase inhibitor 69 HSP# inhibitor 69 HMG CoA reductase inhibitors 69 Hormone Refractory Prostate Cancer 69 Presents Preclinical Data 69 leukemia AML 69 WRX STi +# mins 69 Navelbine ® 69 benzoic acid hyoscyamine sulfate 69 Aliskiren 69 % pramoxine HCl 69 Solution XOPENEX HFA 69 somatostatin analogue 69 soluble tumor necrosis 69 Serostim R 69 Orthop Surg 69 Dementia Related Psychosis 69 selective inhibitor 69 neutropenia dehydration dyspnea 69 docetaxel Taxotere 69 IMiDs ® compound 69 antibody MAb 69 Methylnaltrexone 69 memantine HCl 69 Pharmacokinetic Study 69 nucleotide analogue 69 ODT metoclopramide HCl PEPCID 69 ® EBLY ® MASTERFOODS 69 'S ® DOLMIO 68 5 HT6 receptor 68 Nat Clin Pract 68 oral nucleoside analogue 68 potent CYP#A# inhibitors 68 Advanced Renal Cell 68 Nebulized 68 CDK inhibitor 68 reversible inhibitor 68 Cyclophosphamide 68 Tesetaxel 68 panitumumab Vectibix 68 systemic anaplastic large 68 BY SUE KIESEWETTER 68 trastuzumab Herceptin ® 68 sarcoma melanoma 68 immunomodulator 68 EGFR tyrosine kinase inhibitor 68 Protease Inhibitor 68 IMiDs R 68 mTOR inhibitor 68 Metastatic Melanoma 68 B lymphocyte stimulator 68 pertuzumab 68 Neulasta R 68 refractory NSCLC 68 DOXIL 68 INSPIRE Trial Phase III 68 Bortezomib 68 interleukin IL -# 68 Loceryl ® 68 nucleoside analog 68 irinotecan containing 68 HYVISC ® treatment 68 lexidronam injection 68 Intravenous Human 68 Acetate Rectal Suppositories 68 Telik logo TELINTRA 68 radiation sensitizer 68 Coadministration 68 Cream Hydrocortisone Cream USP 68 Known hypersensitivity 68 Liposomal 68 Preclinical Study 68 Preclinical Data 68 II Clinical Trial 68 Dose Ranging Study 68 Janus kinase 68 meropenem 68 Quinamed 68 nilotinib Tasigna 68 mGluR5 negative 68 echinocandin 68 Suppository Hydrocortisone Acetate Rectal 68 PNP inhibitor 68 aripiprazole Abilify 68 CCX# B 68 TRAIL R2 68 Tyrosine Kinase Inhibitor 68 J Am Acad 68 Antigen Specific 68 METOZOLV TM ODT metoclopramide 68 MyVax R 68 Teriflunomide 68 Staphylococcus aureus Immune Globulin 68 Dermatol 68 DNA methyltransferase inhibitors 68 Myelodysplastic Syndrome MDS 68 Lymphocytic 68 selective agonist 68 Adjuvant Treatment 68 solithromycin 68 peripherally acting 68 Bevacizumab 68 Wafer polifeprosan 68 metabolic disorders Saizen R 68 M2 subunit 68 Treatment Naïve 68 histone deacetylase HDAC inhibitor 68 Bafetinib 68 Patients Treated With 68 occlusion PAO 68 Receives Orphan Drug Designation 68 Cannabinor 68 ATC ovarian cancer 68 Initiates Enrollment 68 BY EDWARD CARIFIO 68 INCB# [003] 68 Aurora Kinase 68 Antitumor activity 68 BY STEPHANIE A. WILKEN 68 docetaxel Taxotere R 68 Lenocta TM 68 cyclophosphamide Cytoxan 68 Kuvan sapropterin dihydrochloride 68 Mitoxantrone 68 PRT# 68 antiangiogenesis therapies 68 phenyl salicylate methylene blue 68 NOTE POSIDUR ™ 68 metastatic colorectal 68 Anthrax Toxin 68 DG# compounds targeting 68 HCD# [002] 68 Ceflatonin R 68 R memantine HCl 68 Neoadjuvant 68 gastrointestinal stromal tumors GIST 68 Thiarabine 68 refractory gout 68 Metab Disord 68 Cyclooxygenase Inhibiting Nitric Oxide 68 Peginterferon alfa 2a 68 ocular formulation 68 methylnaltrexone bromide 68 cell carcinoma RCC 68 Previously Untreated 68 Soriatane R 68 J Allergy Clin 68 Oritavancin 68 Initiate Phase 68 arsenic trioxide injection 68 amprenavir 68 N acetylgalactosamine 6 68 VELCADE melphalan 68 cyclin dependent kinase inhibitor 68 relapsed MM 68 panitumumab Vectibix R 68 folate analogue metabolic 68 lenalidomide Revlimid ® 68 peginterferon alfa 2a Pegasys 68 paclitaxel Taxol 68 BY WILLIAM ROLLER 68 RAS MAPK pathway 68 Ziprasidone 68 Delafloxacin 68 ziprasidone Geodon 68 selectively inhibits 68 polyglutamate 68 Pioglitazone 68 Soft Tissue Sarcoma 68 TRIOLEX HE# APOPTONE HE# 68 modified glutathione analog 68 YONDELIS 68 paclitaxel cisplatin 68 ribavirin RBV 68 CysDisplay R 68 selective inhibition 68 Palifosfamide 68 AP Photo CAR# 68 Bavituximab 68 Interferon alpha 68 5 fluorouracil leucovorin 68 Seliciclib 68 arsenic trioxide injection GABITRIL 68 PDGFR B 68 EPIVIR 68 anti angiogenic agent 68 ceftazidime 68 JAK2 Inhibitor 68 Epivir R 68 oral dual endothelin 68 targeting CD# 68 generation Hsp# inhibitor 68 Safinamide 68 NS#/#A protease 68 Phase 1b clinical trials 68 semi synthetic lipoglycopeptide 68 Disease IBD 68 Novel Inhibitor 68 Hemispherx flagship products 68 ® DYTEK ® FRESHFX 68 Imatinib mesylate 68 ACTEMRA TM 68 Phase 2b Study 68 daunorubicin 68 Personalized Immunotherapy 68 AN# topical anti 68 Talactoferrin 68 CHEAP ONLINE PHARMACY LOW 68 Demonstrates Positive 68 product candidate Lpathomab 68 mycophenolate mofetil 68 metastatic GIST 68 Itraconazole 67 5 HT2A inverse 67 Vicinium TM 67 brand ciclesonide Nasal 67 infliximab monotherapy 67 oncolytic virus therapies 67 PROCTOCORT ® Suppository Hydrocortisone 67 Antiviral Activity 67 Cyclin Dependent 67 Pegylated 67 receptor inhibitor 67 Pivotal Phase 67 Oral Suspension Oral Suspension 67 oral proteasome inhibitor 67 ABLYNX 67 Phase IIb Clinical Trial 67 investigational pharmacologically unique 67 azoles 67 telomerase therapeutic 67 HDAC Inhibitor 67 T#I [002] 67 Inhalation Aerosol 67 PI3K/Akt pathway inhibitor 67 Tocilizumab 67 candesartan cilexetil 67 diarrhea fatigue asthenia 67 liposomal doxorubicin 67 MANAGEMENT 'S CURRENT BELIEFS 67 K ras mutations 67 cutaneous T 67 etanercept Enbrel 67 Epothilone D 67 Platinol ® cisplatin 67 drug monomethyl auristatin 67 NASH Huntington 67 non peptidic protease 67 paclitaxel Taxol ® 67 octreotide acetate 67 NUVIGIL ® 67 Orally administered 67 nelfinavir Viracept 67 R rilonacept Injection 67 allosteric modulator NAM 67 combines bupropion 67 camptothecin CPT 67 selective phosphodiesterase 67 CDK cyclin dependent 67 selective orally bioavailable 67 dual PPAR peroxisome 67 Drug Candidate 67 armodafinil Tablets C 67 CORDURA ® CORFREE ® 67 Adalimumab 67 toenail onychomycosis 67 Clinical Trial Results 67 vesicular monoamine transporter 67 AVASTIN 67 nucleoside analogues 67 TRANSDUR ™ 67 Ep CAM 67 Melphalan 67 sorafenib Nexavar ® 67 alkylating 67 Daptomycin 67 Angiotensin Converting Enzyme 67 receiving INTRON 67 Vandetanib 67 inhalation aerosol 67 Tibotec Therapeutics division 67 PROCTOCORT R Suppository Hydrocortisone 67 carcinoma mCRC 67 Host Disease 67 Dose Escalation 67 Vidaza R 67 tazobactam 67 Isavuconazole 67 pimozide 67 factor TNF 67 R brand levalbuterol 67 carbamazepine phenobarbital phenytoin rifampin 67 mTOR mammalian target 67 monocyte chemotactic protein 67 HCl PEPCID ® famotidine 67 MT# MEDI 67 Demonstrates Significant 67 Silodosin 67 xenograft models 67 anionic backbone 67 ® famotidine 67 R brand arformoterol 67 MGd 67 including HGF ErbB3 67 Medoxomil 67 Demonstrates Efficacy 67 dihydrochloride 67 PRTX 67 trimethoprim sulfamethoxazole 67 AEG# 67 dihydrochloride Tablets 67 cyclophosphamide chemotherapy 67 idarubicin 67 Novacort TM 67 Fluorouracil 67 TLR7 agonist 67 Interferon gamma 67 TLK# 67 Randomized Double Blind Placebo 67 Capecitabine 67 GRNOPC1 contains 67 tyrosine kinase inhibitor 67 Rigel R# 67 selectively inhibited 67 CYC# 67 vaginal candidiasis 67 Castration Resistant Prostate Cancer 67 gastrointestinal stromal 67 Emtriva Viread 67 alvespimycin 67 Seasonal Allergic Rhinitis 67 Newly Diagnosed Multiple Myeloma 67 azacytidine 67 investigational monoclonal antibody 67 dyskinesia PD LID 67 forodesine purine nucleoside phosphorylase 67 methylergonovine 67 PEG SN# 67 molecule epidermal 67 investigational immunotherapy 67 rivastigmine Exelon 67 tartrate Inhalation Aerosol BROVANA 67 PegIFN 67 Recombinant Human 67 PDX pralatrexate 67 PROCTOCORT R Cream Hydrocortisone 67 Platinol ® 67 Advanced Melanoma 67 Maribavir 67 Plus Ribavirin 67 CTAP# 67 metastatic renal cell carcinoma 67 plasma kallikrein inhibitor 67 systemic juvenile idiopathic 67 purpura ITP 67 fluoropyrimidine 67 Lubiprostone 67 Darinaparsin 67 Deforolimus 67 Child Adolesc Psychiatry 67 regulated kinase 67 Denufosol 67 pegylated interferon alfa 2a 67 novel nucleoside analog 67 influenza BCX# purine nucleoside 67 humanized therapeutic 67 topically applied SEPA 67 alkylating agent 67 8mg/kg 67 Posaconazole 67 vincristine doxorubicin 67 brivanib 67 clozapine Clozaril 67 adecatumumab MT# 67 Investigational eFlow Nebulizer System 67 cortisol synthesis 67 mg Suppository Hydrocortisone Acetate 67 MT#/MEDI-# 67 Clolar ® 67 Romidepsin 67 Int J Radiat Oncol 67 erlotinib Tarceva 67 LENALIDOMIDE 67 HCV NS5B polymerase 67 PEGylated interferon beta 1a 67 Is Well Tolerated 67 PEGINTRON TM 67 Metastatic Renal Cell Carcinoma 67 Vaccine Adjuvant 67 small molecule Hedgehog 67 Kit CD# positive 67 estrogen receptor antagonist 67 systemic RNAi therapeutic 67 POLYSHIELD ® POLYCLEAR ® 67 Budesonide foam crofelemer 67 5HT 67 Aztreonam lysine 67 Kahalalide F 67 non thiazolidinedione TZD 67 Pivotal Phase III 67 sorafenib Nexavar R 67 MEK Inhibitor 67 tenofovir Viread 67 CANCIDAS 67 selective inverse agonist 67 topoisomerase II inhibitor 67 Interferon beta 1a 67 DIURIL R 67 rheumatoid arthritis RA psoriatic 67 Symbioscience WISDOM PANEL 67 WX UK1 67 oropharyngeal candidiasis OPC 67 Crizotinib PF # 67 denileukin diftitox 67 Neulasta ® 67 Moxifloxacin 67 metastatic neuroendocrine tumors 67 Metastatic Prostate Cancer 67 Pazopanib 67 Treatment Naive Patients 67 pharmacologically active isomer 67 pharmacokinetic interactions 67 gemcitabine Gemzar ® 67 Leukemia AML 67 gemcitabine carboplatin 66 FOLOTYN ® 66 Synta Announces 66 targeted radiotherapeutic 66 docetaxel chemotherapy 66 BY DAVID KRECHEVSKY 66 Sandostatin R 66 humanised monoclonal antibody 66 mecamylamine 66 included exfoliative dermatitis 66 Potassium Chloride Sodium Ascorbate 66 CIMZIA ™ 66 Gel repository corticotropin injection 66 hydroxymethyl coenzyme 66 alefacept 66 FOLFIRI 66 including thyroiditis RA 66 vidofludimus 66 D. CIMBUREK 66 interferon alfa 2b 66 Golimumab 66 Alinia 66 sunitinib malate 66 FUSILEV ® 66 caspofungin 66 4 PDE4 enzyme 66 alfa 2b 66 ribavirin Copegus ® 66 COMPANY ASSUME ANY RESPONSIBILITY 66 Primary Hypercholesterolemia 66 Immunomodulatory 66 potent inhibitor 66 PEGASYS ® 66 hypoxia inducible factor 66 HER2 positive metastatic breast 66 Novartis Trileptal 66 lansoprazole Prevacid 66 prednisone prednisolone plus 66 Adenoviral 66 iobenguane 66 catheter occlusion 66 Achieves Primary Endpoint 66 gastrointestinal stromal tumor GIST 66 Oral Solution VISICOL 66 LymphoStat B TM 66 Randomized Phase II 66 secretory phospholipase A2 66 vinorelbine tartrate 66 Alocrest 66 plus gemcitabine 66 Etoposide 66 Cytotoxic T 66 Phase #b/#a clinical 66 Completes Enrollment 66 Sudhir Agrawal D.Phil 66 DAVANAT 66 SPL# Gel vaginal microbicide 66 indolent follicular non 66 Aplidin 66 ENL recurrence 66 Kinoid 66 signal transduction inhibitor 66 J Antimicrob Chemother 66 oral Janus kinase 66 ARE ONLY PREDICTIONS 66 DURECT proprietary 66 sphingosine kinase 66 Am J Clin 66 methionine aminopeptidase 66 See CONTRAINDICATIONS 66 BY ERIN GUERRA 66 Novel Compound 66 BENLYSTA TM 66 targeting miR 66 S. intermedius 66 oxaliplatin Eloxatin 66 myocardial infarction ventricular fibrillation 66 atazanavir Reyataz 66 Cloretazine ® 66 R abacavir sulfate 66 ACTIQ ® 66 attach auristatin 66 stage IIIb IV 66 Monopril 66 crizotinib PF # 66 BY KEVIN LITTEN 66 resistant hormone refractory 66 hypoxia activated prodrug 66 Initiates Phase II 66 HCV RNA polymerase 66 PATENT FOR 66 Tumor necrosis factor 66 pentadentate logo R 66 Tarceva TM 66 AKT inhibitor 66 HER1 66 known dihydropyrimidine dehydrogenase 66 GVAX ® 66 tumor activated prodrug 66 unique alkylating agent 66 Xyfid TM 66 BY DREW SHARP 66 Novacort R 66 Natalizumab 66 teriflunomide 66 temsirolimus Torisel ® 66 CAREFULLY READ THESE MATERIALS 66 anti amnesic 66 huC# DM4 66 Anthracycline 66 infliximab Remicade 66 Initiates Clinical Trial 66 DFMO 66 lintuzumab SGN 66 TNF alpha selectively neutralizing 66 sunitinib Sutent 66 novel synthetic peptide 66 EXECUTIVE SUMMARY II 66 Granulocyte Colony Stimulating Factor 66 BY CHRIS GARDNER 66 Parkinson disease levodopa induced 66 PROSTASCINT R 66 basiliximab 66 mitoxantrone plus 66 NS5b 66 stage IIIB 66 Shows Promising 66 IV FENTORA R 66 selective adhesion molecule 66 chimeric monoclonal antibody 66 Camptosar ® irinotecan 66 Mycophenolate Mofetil 66 Proc Am Soc 66 cromolyn sodium 66 Cloretazine VNP#M 66 Epivir 66 AND UNKNOWN COULD CAUSE 66 IN DIAMETER 66 J Am Coll 66 serologically active systemic lupus 66 EGFR TKI 66 alpha TNFa 66 Veronate R 66 platform HDL Mimetic 66 cisplatin carboplatin 66 capecitabine Xeloda ® 66 boosted protease inhibitor 66 Aptivus ® 66 THAT ARE SUBJECT TO 66 Treatment Experienced 66 dopamine D2 66 esomeprazole Nexium 66 immunostimulatory 66 liver colon rectal 66 RhuDex TM 66 cis retinoic acid 66 Telaprevir VX 66 Leukine ® 66 BY MARC SILVESTRINI 66 By Ed Edelson 66 interferon alfa 66 MET VEGFR2 66 XOMA 3AB biodefense 66 * olmesartan medoxomil 66 specific lectin receptors 66 TH STAFF WRITER 66 WEATHER OFFICE 66 Androgen Receptor 66 DIURIL ® Chlorothiazide AZASAN 66 mRCC 66 hypoxia selective 66 2 inhibitor CYT# 66 F. PARTLOW 66 ® bortezomib 66 agent VDA 66 generation nucleoside analog 66 Luteinizing Hormone Releasing Hormone 66 Eluting Stent 66 vaccine RiVax TM 66 ® adefovir dipivoxil 66 Teva Provides Update 66 Infected Patients 66 fentanyl buccal tablet 66 IMA# 66 5 FU capecitabine 66 relapsed multiple myeloma 66 pyrexia mucositis sepsis febrile 66 generation antisense inhibitor 66 small molecule tyrosine 66 Gefitinib 66 nevirapine Viramune 66 doxorubicin cyclophosphamide 66 trastuzumab DM1 T DM1 66 pDC 66 Vaccine Recombinant 66 HuMax EGFr 66 cisplatin resistant 66 DOXIL R 66 BAY #-# 66 TKB# 66 Saizen ® 66 Novel Antibiotic 66 MKC# MKC# PP 66 Ph + acute lymphoblastic 66 TAFA# 66 haloperidol Haldol 66 Relapsed Refractory Multiple Myeloma 66 protease inhibitor PI 66 sodium benzoate prescription 66 DNA intercalator 66 BY JONATHAN SHUGARTS 66 Chronic Myeloid Leukemia 66 RNAi Therapeutic 66 IgG1 monoclonal antibody 66 EGFr 66 #HT# 66 hyaluronidase enzyme 66 lamivudine 3TC 66 Nexavar sorafenib 66 THE OFFER DOCUMENTS 66 JOHNSON POST DISPATCH 66 Temsirolimus 66 Pruvel ™ 66 BY PAUL SINGLEY 66 Zolinza 66 Files IND 66 Renal Impairment 66 Gel BUPHENYL R 66 Anticancer Drugs 66 MTP inhibitor 66 long acting muscarinic 66 Bezielle 66 METOZOLV ™ ODT metoclopramide 66 Tyrima 66 interferon alfa 2a 66 DEB# 66 Parathyroid Hormone 66 substantially excreted 66 BY MARK FARINELLA 66 investigational oral hepatitis C 66 q#h 66 mitomycin 66 visilizumab 66 Boceprevir 66 Ann Oncol 66 potent antiproliferative 66 HuMax 66 T. MADORE 66 Pralatrexate 66 complement inhibitor eculizumab